These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27040868)

  • 21. Playing God? Media coverage of CRISPR in the United States.
    Stapleton P; Torres Yabar A
    Public Underst Sci; 2023 May; 32(4):504-521. PubMed ID: 36527362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
    Li W; Ou G
    Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticipating Emerging Biotechnology Threats:
    Vogel KM; Ouagrham-Gormley SB
    Politics Life Sci; 2018 Dec; 37(2):203-219. PubMed ID: 31120699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the CRISPR/Cas9 gene editing technique to research on functional genomes of parasites.
    Cui Y; Yu L
    Parasitol Int; 2016 Dec; 65(6 Pt A):641-644. PubMed ID: 27586395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
    Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
    J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR in the North American popular press.
    Marcon A; Master Z; Ravitsky V; Caulfield T
    Genet Med; 2019 Oct; 21(10):2184-2189. PubMed ID: 30976097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 31. Application of the genome editing tool CRISPR/Cas9 in non-human primates.
    Luo X; Li M; Su B
    Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization analysis of CRISPR/Cas9 gene editing technology studies.
    Du QS; Cui J; Zhang CJ; He K
    J Zhejiang Univ Sci B; 2016 Oct.; 17(10):798-806. PubMed ID: 27704749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Bacterial Origins of the CRISPR Genome-Editing Revolution.
    Sontheimer EJ; Barrangou R
    Hum Gene Ther; 2015 Jul; 26(7):413-24. PubMed ID: 26078042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CRISPR reimagining: New twists and turns of CRISPR beyond the genome-engineering revolution.
    Plummer RJ; Guo Y; Peng Y
    J Cell Biochem; 2018 Feb; 119(2):1299-1308. PubMed ID: 28926145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR Editing in Biological and Biomedical Investigation.
    Ju XD; Xu J; Sun ZS
    J Cell Biochem; 2018 Jan; 119(1):52-61. PubMed ID: 28543738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of CRISPR genome editing technology in drug target identification and validation.
    Lu Q; Livi GP; Modha S; Yusa K; Macarrón R; Dow DJ
    Expert Opin Drug Discov; 2017 Jun; 12(6):541-552. PubMed ID: 28388235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.